tirzepatide and cannabis on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial 📖 Read the most popular

A 5mg vial at 0.25mg weekly lasts 20 weeks

It is the dose that supports meaningful progress while allowing the patient to eat, hydrate, function, preserve muscle, and maintain follow-up

This hormonal shift causes the metabolic rate to slow by approximately 28% per decade, making it harder to maintain weight even without changes in diet or exercise

Warda, M

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, and related metabolic pathwayspredispositions that may help provide context for how your body responds to consistent GLP-1 exposure over time

2025 Nov 13;82(1):396